| Name | Title | Contact Details |
|---|
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
Galen Healthcare Solutions is a Burlington, VT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mizell Memorial Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Mizell Memorial Hospital is based in Opp, AL. You can find more information on Mizell Memorial Hospital at www.mizellmh.com
Jewish Hospital and St. Mary's HealthCare, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Louisville, KY. To find more information about Jewish Hospital and St. Mary's HealthCare, Inc., please visit www.jhsmh.org
Rising Medical Solutions is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.